Semaglutide Use in Diabetes Doubles Risk of Irreversible Vision Loss, claims study Dr Riya Dave3 Jan 2025 11:15 AM ISTResearchers have established that the application of once-weekly semaglutide in patients with type 2 diabetes (T2D) increases the risk of nonarteritic...
Metformin Use may Reduce Risk of Sudden Hearing Loss in Diabetes Patients: Study Dr Riya Dave3 Jan 2025 9:00 AM ISTResearchers have observed that the antidiabetic agent, metformin widely used for Type 2 diabetes, reduced the risk for developing sudden sensorineural...
Higher Potassium Intake Linked to Lower Cardiovascular Risk in Diabetes, reveals research Dr Riya Dave2 Jan 2025 8:45 AM ISTResearchers have shown that higher potassium intake has been linked to significantly reduced risks of major cardiovascular events in patients with...
Poor Glycemic Control Not tied to Increased Infection Risk in Diabetes patients, finds study Dr Riya Dave30 Dec 2024 8:30 AM ISTResearchers have discovered that long-term glycemic control does not affect the risk of bacterial infection in type 2 diabetes patients. A recent...
Cutaneous Carbonyl Stress Linked to Nerve Dysfunction and Neuropathy Risk in Recent-Onset Type 2 Diabetes: Study Medha Baranwal28 Dec 2024 8:45 AM ISTGermany: A study published in Diabetes Care reveals that elevated cutaneous carbonyl stress is linked to slower nerve conduction in patients with...
Semaglutide with Metformin Improves Liver Health and Pancreatic Function in T2DM and NAFLD: Study Reveals Medha Baranwal26 Dec 2024 9:00 AM ISTChina: A recent study revealed that combining semaglutide and metformin significantly improved liver inflammation, fibrosis, and pancreatic beta-cell...
Systolic BP of less than 120 mm Hg reduced CVD risk in adults with Type 2 diabetes, suggests study Dr. Kamal Kant Kohli26 Dec 2024 8:00 AM ISTAn intensive treatment approach to lowering high systolic blood pressure in people with Type 2 diabetes led to a reduced risk of heart attack, stroke,...
FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Diabetes patients Dr. Kamal Kant Kohli24 Dec 2024 8:15 PM ISTThe U.S. Food and Drug Administration approved the first generic referencing Victoza (liraglutide injection) 18 milligram/3 milliliter, a...
Biocon, Zentiva gets Decentralized Procedure approval for generic diabetes, weight management drug in EU Ruchika Sharma24 Dec 2024 11:36 AM ISTBangalore: Biocon and its European partner, Zentiva, have received a Decentralized Procedure (DCP) approval for its complex...
Positive Results for Mifepristone in Treating Hypercortisolism and Type 2 Diabetes: CATALYST Trial Medha Baranwal24 Dec 2024 8:00 AM ISTUSA: Mifepristone (Korlym) shows significant HbA1c improvement in hypercortisolism and difficult-to-control diabetes; Corcept announces positive...
Diabetes Drugs SGLT2i and GLP-1 RAs may Reduce Risk of Pneumonia and Sepsis, finds research Dr Riya Dave19 Dec 2024 8:15 AM ISTResearchers have discovered that sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs), often...
Cutaneous carbonyl stress markers associated with nerve damage in recent-onset type 2 diabetes: Study Jacinthlyn Sylvia18 Dec 2024 9:00 AM ISTA new study showed that in recent-onset type 2 diabetes, cutaneous carbonyl stress biomarker could indicate nerve damage. The key findings of...
